Want to join the conversation?
$AVY 2Q15 Q&A: Kapsch of BB&T Capital Market asked if raw material benefit was second largest YoverY with productivity being largest. Dean answered that volume mix was the second largest. It's very consistent with where the company has mentioned the benefit on net price between raws and the pricing element as it's not negligible.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?